Risperidone
Product Images NDC 58165-032

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Risperidone (NDC 58165-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ratiopharm Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0-25mg (0 25mg)

FDA Label Image

0-5mg (0 5mg)

This is a description of Risperidone Tablets manufactured and distributed by Ratiopharm. The dosage comes with a package and should be kept out of reach of children. It is a prescription medicine sold in the United States. The manufacturer is located in Canada and the distributor is based in Ronse, Belgium.*

FDA Label Image

1mg (1mg)

This is a package of Risperidone tablets, which is a prescription medication that is used to treat schizophrenia and bipolar disorder. The package contains 150 tablets, and the dosage strength is not indicated. The manufacturer is Ratiopharm, and the package is intended for single use. The rest of the text is not available for evaluation as it contains nonsensical and non-English characters.*

FDA Label Image

2mg (2mg)

FDA Label Image

3mg (3mg)

FDA Label Image

4mg (4mg)

FDA Label Image

Stuctural Formula (Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.